default author photo

Aldéric Fraslin

University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy

55 Avenue de Paris

Versailles, 78000

France

  • University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy

SCHOLARLY PAPERS

2

DOWNLOADS

137

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Cetuximab, Docetaxel and Cisplatin as First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results of the GORTEC 2014-01 TPExtreme Randomized Trial

Number of pages: 31 Posted: 05 Oct 2020
Joël Guigay, Anne Aupérin, Jerome Fayette, Esma Saada-Bouzid, Cédrik Lafond, Miren Taberna, Lionnel Geoffrois, Laurent Martin, Olivier Capitain, Didier Cupissol, Hélène Castanie, Damien Vansteene, Philippe Schafhausen, Alison Johnson, Caroline Even, Christian Sire, Sophie Duplomb, Camille Evrard, Jean-Pierre Delord, Brigitte Laguerre, Sylvie Zanetta, Cécile Chevassus, Aldéric Fraslin, Fanny Louat, Laura Sinigaglia, Ulrich Keilholz, Jean Bourhis, Ricard Mesia and GORTEC AIO TTCC UniCancer H&N Group
Centre Antoine Lacassagne - Department of Medical Oncology, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, University of Claude Bernard Lyon 1 - Medical Oncology Department, Centre Antoine Lacassagne, ILC Centre Jean Bernard/Clinique Victor Hugo - Department of Medical Oncology, Institut Català de Oncologia - Department of Medical Oncology, Institut de Cancérologie de Lorraine - Department of Medical Oncology, Clinique des Ormeaux - Department of Medical Oncology, Institut de Cancérologie de l’Ouest Paul Papin - Department of Medical Oncology, Institut de Cancérologie de Montpellier - Department of Medical Oncology, Hôpital Privé le Confluent - Department of Medical Oncology, Institut de Cancérologie de l’Ouest René Gauducheau - Department of Medical Oncology, Centre Antoine Lacassagne - Department of Medical Oncology, Centre François Baclesse - Department of Medical Oncology, Gustave Roussy - Department of Head and Neck Oncology, Centre Hospitalier de Bretagne Sud - Department of Medical Oncology, Hôpital de la Croix Rousse - Department of Medical Oncology, Université de Poitiers - Medical Oncology Department, Institut Claudius Regaud - Department of Medical Oncology, Centre Eugène Marquis - Department of Medical Oncology, Centre Georges-François Leclerc - Department of Medical Oncology, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Charité Comprehensive Cancer Center, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Autonomous University of Barcelona - Medical Oncology Department and Independent
Downloads 111 (635,507)

Abstract:

Loading...

head and neck cancer, squamous cell carcinoma, recurrent, metastatic, Chemotherapy, cetuximab, taxane.

2.

A Microsimulation Model Based on Healthcare Pathways to Estimate the Impact of Covid-19 Pandemic-Induced Delays on Breast Cancer Mortality

Number of pages: 19 Posted: 18 Feb 2025
Aldéric Fraslin, Tom Stockholm, Thomas Filleron, Aurelie bertaut, Audrey Blanc-Lapierre, Jamila Marghadi, Anne Aupérin and Julian Bonastre
University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, Gustave Roussy, Institut Claudius Regaud, Centre Georges-François Leclerc, affiliation not provided to SSRN, Gustave Roussy, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy and Gustave Roussy
Downloads 26 (1,385,945)

Abstract:

Loading...

microsimulation model, COVID-19, delay, breast cancer mortality, healthcare pathways, medico-administrative data